EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluación de la Calidad de vida en pacientes con enfermedadinflamatoria intestinal: Un análisis muticéntrico en Latinoamerica

K. Villa Ovalles, J. Pérez Baldioceda, L. Ortega Giordanelli, P. Núñez Figueroa, NM. García Cárdenas, R. Franco Vásquez, OM. Díaz Espaillat, C. Azañedo Barrantes, N. Aguilar Estay, AH. Yapor Colón, A. Sánchez Orozco

Revista Dominicana de Gastroenterología · 15.01.2026 · 1 (01) · 40-48

DOI: 10.66464/dcbscj51 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Dominicana de Gastroenterología, online erschienen am 15.01.2026. Verfasst von K. Villa Ovalles und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory Bowel Disease (IBD) significantly affects health-related quality of life (HRQoL), particularly in regions with unequal access to advanced therapies, such as Latin America. Although traditional clinical indices allow assessment of inflammatory activity, they fail to capture the patient’s subjective experience and the emotional, functional, and social burden of the disease.

Objective

To identify factors associated with HRQoL in patients with IBD across five Latin American countries, to assess its relationship with clinical severity, and to describe differences according to disease type.

Methods

Multicenter, cross-sectional study conducted between July 2023 and September 2024. HRQoL was measured using the IBDQ-32 questionnaire, and clinical activity was evaluated using the Harvey-Bradshaw Index for Crohn’s disease (CD) and the Modified Mayo Score for ulcerative colitis (UC). Associations with clinical, demographic, and psychosocial variables were analyzed.

Results

A total of 149 patients were included. UC was the predominant condition (72.48%). Patients with CD had higher rates of clinical remission (58.54%) and better HRQoL scores, whereas UC was associated with greater inflammatory activity and higher emotional burden. Clinical severity, female sex, and disease type were significantly associated with HRQoL.

Conclusions

HRQoL in IBD is influenced by factors beyond clinical activity alone. Emotional impact, functional limitations, uncertainty regarding disease flares, and regional variability in access to treatment contribute substantially to overall patient well-being. Incorporating patient-reported outcomes (PROs) should be considered an essential component of IBD management in Latin America.

Zitieren

APA

Ovalles, K. V., Baldioceda, J. P., Giordanelli, L. O., Figueroa, P. N., Cárdenas, N. G., Vásquez, R. F., Espaillat, O. D., Barrantes, C. A., Estay, N. A., Colón, A. Y., & Orozco, A. S. (2026). Evaluación de la Calidad de vida en pacientes con enfermedadinflamatoria intestinal: Un análisis muticéntrico en Latinoamerica. Revista Dominicana de Gastroenterología, 1(01), 40-48. https://doi.org/10.66464/dcbscj51

Vancouver

Ovalles KV, Baldioceda JP, Giordanelli LO, Figueroa PN, Cárdenas NG, Vásquez RF, et al. Evaluación de la Calidad de vida en pacientes con enfermedadinflamatoria intestinal: Un análisis muticéntrico en Latinoamerica. Revista Dominicana de Gastroenterología. 2026;1(01):40-48. doi:10.66464/dcbscj51

BibTeX
@article{Ovalles2026,
  author = {Ovalles, K. Villa and Baldioceda, J. Pérez and Giordanelli, L. Ortega and Figueroa, P. Núñez and Cárdenas, NM. García and Vásquez, R. Franco and Espaillat, OM. Díaz and Barrantes, C. Azañedo and Estay, N. Aguilar and Colón, AH. Yapor and Orozco, A. Sánchez},
  title = {Evaluación de la Calidad de vida en pacientes con enfermedadinflamatoria intestinal: Un análisis muticéntrico en Latinoamerica},
  journal = {Revista Dominicana de Gastroenterología},
  year = {2026},
  volume = {1},
  number = {01},
  pages = {40--48},
  doi = {10.66464/dcbscj51}
}
Kostenlos starten →